These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31315438)

  • 1. Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events-Brief Report.
    Henson D; Tahhan AS; Nardo D; Quyyumi AA; Venditto VJ
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1884-1892. PubMed ID: 31315438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ApoA-I IgG antibodies are not associated with carotid artery disease progression and first-time cardiovascular events in middle-aged individuals.
    Lagerstedt JO; Dalla-Riva J; Marinkovic G; Del Giudice R; Engelbertsen D; Burlin J; Petrlova J; Lindahl M; Bernfur K; Melander O; Nilsson J; Schiopu A
    J Intern Med; 2019 Jan; 285(1):49-58. PubMed ID: 30028049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Bastardot F; Hartley O; Montecucco F; Mach F; Waeber G; Vollenweider P; Vuilleumier N
    Thromb Haemost; 2016 Sep; 116(4):764-71. PubMed ID: 27384400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
    Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
    Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
    Bridge SH; Pagano S; Jones M; Foster GR; Neely D; Vuilleumier N; Bassendine MF
    Hepatol Int; 2018 Jan; 12(1):17-25. PubMed ID: 29423541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
    Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
    Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
    Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
    Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
    J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
    Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
    J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives.
    Teixeira PC; Cutler P; Vuilleumier N
    Clin Dev Immunol; 2012; 2012():868251. PubMed ID: 23227091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy.
    Vuilleumier N; Montecucco F; Spinella G; Pagano S; Bertolotto M; Pane B; Pende A; Galan K; Roux-Lombard P; Combescure C; Dallegri F; Mach F; Palombo D
    Thromb Haemost; 2013 Apr; 109(4):706-15. PubMed ID: 23364307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.
    Carbone F; Satta N; Montecucco F; Virzi J; Burger F; Roth A; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Lalive PH; Mach F; Fainardi E; Vuilleumier N
    Eur J Clin Invest; 2016 Sep; 46(9):805-17. PubMed ID: 27490973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy.
    Asciutto G; Dias NV; Edsfeldt A; Alm R; Fredrikson GN; Gonçalves I; Nilsson J
    Atherosclerosis; 2015 Apr; 239(2):289-94. PubMed ID: 25682025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study.
    Croca S; Bassett P; Chambers S; Davari M; Alber KF; Leach O; Ioannou Y; Giles I; Isenberg D; Rahman A
    Arthritis Res Ther; 2015 Feb; 17(1):26. PubMed ID: 25890187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.
    Natarajan P; Collier TS; Jin Z; Lyass A; Li Y; Ibrahim NE; Mukai R; McCarthy CP; Massaro JM; D'Agostino RB; Gaggin HK; Bystrom C; Penn MS; Januzzi JL
    J Am Coll Cardiol; 2019 May; 73(17):2135-2145. PubMed ID: 31047001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.